ULTY, SMCZ: Significant Withdrawals from ETFs
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 22 2025
0mins
Source: NASDAQ.COM
ETF Outflow Details: The Defiance Daily Target 2X Short SMCI ETF experienced the largest outflow, losing 2,240,000 units, which is a 38.6% decrease in outstanding units compared to the previous week.
Market Commentary: The views expressed in the article are those of the author and do not necessarily represent the opinions of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RKLB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RKLB
Wall Street analysts forecast RKLB stock price to fall
11 Analyst Rating
7 Buy
4 Hold
0 Sell
Moderate Buy
Current: 109.250
Low
63.00
Averages
86.89
High
120.00
Current: 109.250
Low
63.00
Averages
86.89
High
120.00
About RKLB
Rocket Lab Corporation is an end-to-end space company. The Company designs and manufactures small and medium-class rockets, spacecraft and spacecraft components, and related software and services to support the space economy. The Company delivers reliable launch services, satellite manufacture, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions that make it easier to access space. Its Launch Services segment provides launch and launch-related services to customers on a dedicated mission or ride-share basis. Its Space Systems segment comprises the design and manufacture of spacecraft components and spacecraft program management services, space data applications, and mission operations. Its space systems solutions are the building blocks for spacecraft, which include composite structures, reaction wheels, star trackers, solar solutions, radios, separation systems, and command and control spacecraft software.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Impact of SpaceX IPO: SpaceX's successful IPO has made it the largest in history with a market cap of $2.1 trillion, causing a 32% drop in Rocket Lab's stock as investor focus shifts away from other space economy stocks.
- Rocket Lab Revenue Growth: Despite the stock decline, Rocket Lab reported $680 million in revenue over the past 12 months, reflecting a remarkable 1,000% growth over the last five years, indicating strong potential in the space launch market.
- Neutron Rocket Development: Rocket Lab is developing a larger Neutron rocket, expected to debut later this year, which should significantly boost revenue generation and attract more commercial clients to its launch services, enhancing its market position.
- Investor Strategy Advice: Given the high P/S ratios of both SpaceX and Rocket Lab, analysts recommend that investors exercise caution and consider seeking alternative investment opportunities to mitigate high risks.
See More
- Market Dynamics: In the first half of 2023, the stock market performed strongly with Q1 earnings exceeding expectations by 20%, primarily driven by the tech sector, reflecting robust investor confidence despite ongoing inflation and rising interest rate concerns.
- AI Investment Surge: The demand for AI capital expenditures is described as 'insatiable', with the market continuing to rise despite increasing oil prices and interest rates, indicating a widespread recognition of the long-term potential in the AI sector that could lead to significant capital inflows into related stocks.
- IPO Market Outlook: A substantial number of IPOs are expected in the second half of the year, particularly from major players like SpaceX and OpenAI, with total fundraising projected to reach $150 billion, approximately 25% of the capital raised in 2021, which will significantly impact market liquidity.
- Investment Strategy Adjustments: As market volatility increases, investors need to approach with caution, particularly in defensive stocks and energy sectors, where capital outflows may occur, suggesting that investors should leverage this opportunity for asset reallocation to navigate future uncertainties.
See More
- Short-Term Bearish Trends: According to S3's analysis, ASTS and SPCE are identified as the clearest bearish bets in the space sector, with ASTS's short position reaching 54 million shares, a 41% increase year-to-date, while SPCE's surged 86% to 28 million shares, indicating strong market skepticism towards these stocks.
- Investor Behavior Shift: Despite LUNR being heavily shorted, passive ownership has surged 101% year-to-date, reflecting growing confidence among long-term investors, with active and hedge fund long positions increasing by 52% and 97% respectively, outpacing the stock's 34% short interest growth.
- Short Covering Phenomenon: Short positions in RKLB and VSAT have decreased by 22% and 26% year-to-date, respectively, indicating investor recognition of improved fundamentals in these cash-generating companies, suggesting a more optimistic outlook for their future performance.
- Market Sentiment Analysis: On Stocktwits, retail sentiment towards SPCX is deemed 'bullish', while ASTS, SPCE, and RKLB also show 'bullish' sentiment, indicating an overall increase in market confidence in space stocks, despite VSAT and PL leaning towards 'bearish' sentiment.
See More
- Launch Delay Reason: Rocket Lab announced a delay for the 'Ten Owl Of Ten' mission to conduct additional pre-flight checkouts, originally scheduled for June 18 from New Zealand, which may impact future launch plans for the company.
- Ongoing Customer Partnership: Since 2020, Rocket Lab has been Synspective's sole launch provider, and this mission will mark their tenth dedicated launch, indicating the stability and longevity of their partnership.
- Positive Market Reaction: Despite the launch delay, Rocket Lab's shares rose 1% on Wednesday after a 4% drop on Tuesday, reflecting investor confidence in the company's long-term prospects, especially with a 294% stock price increase over the past year.
- Satellite Deployment Plans: The upcoming mission will deploy a StriX synthetic aperture radar satellite, providing Earth observation data for urban development, infrastructure monitoring, and disaster response, further solidifying Rocket Lab's position in the Japanese market.
See More
- Record IPO: SpaceX's successful IPO has established a market cap of $2.1 trillion, making it the seventh-largest company globally, which may divert capital from other space economy stocks, impacting their price performance.
- Starlink Revenue Growth: The Starlink business has achieved $11.4 billion in annual revenue, growing 50% year-over-year, providing crucial support for SpaceX's overall revenue and is expected to continue driving growth and enhancing market competitiveness.
- Rocket Lab's Market Potential: Rocket Lab's revenue has surged to $680 million over the past 12 months, reflecting a 1,000% increase over five years, showcasing its strong performance in the space launch market despite competition from SpaceX.
- Future Development Strategy: Rocket Lab plans to debut its larger Neutron rocket, which is expected to significantly boost revenue, although its stock remains expensive with a market cap of $60 billion and a P/S ratio of 89, prompting investors to carefully assess risks.
See More
- Market Rally Assessment: Markets are taking a breather as investors reassess the recent rally driven by easing tensions in the Middle East, particularly ahead of the Federal Reserve's first policy meeting under Chair Kevin Warsh, where interest rates are expected to remain steady, reflecting cautious sentiment regarding future policy directions.
- SpaceX Stock Frenzy: SpaceX shares crossed a $2.5 trillion valuation on Monday, although Wall Street analysts are raising concerns about high valuations, especially as veteran short-seller Jim Chanos warns that investors rarely profit from buying companies valued at more than 100 times revenue, which may impact retail investor confidence.
- Novo Nordisk's China Plans: Novo Nordisk announced plans to seek regulatory approval for its oral Wegovy weight-loss pill in China within the next few months, aiming to challenge Eli Lilly's market position, indicating its strategic intent to expand in the Chinese market.
- Economic Data Focus: Investors are closely tracking the upcoming release of the U.S. ADP weekly employment change and housing starts data, which will provide further directional guidance for the market, especially in the context of the Federal Reserve's policy decisions.
See More










